Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DURECT Corp (NASDAQ:DRRX)

1.01
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
0.74
Today|||52-Week Range
2.17
-24.63%
Year-to-Date
No recent news for DURECT Corp.

Today’s Trading

Previous close1.01
Today’s open0.97
Day’s range0.97 - 1.05
Volume960,071
Average volume (3 months)787,384
Market cap$150.0M
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)-36.84%
Earnings growth (this year)+33.33%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-26.66%
P/E ratioNM
Price/Sales12.72
Price/Book17.12

Competitors

 Today’s
change
Today’s
% change
NEOSNeos Therapeutics In...0.000.00%
CPRXCatalyst Pharmaceuti...0.000.00%
OVIDOvid Therapeutics In...0.000.00%
ABUSArbutus Biopharma Co...0.000.00%
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$14.0M
Annual profit (last year)-$34.5M
Net profit margin-246.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Scientific Officer
Felix Theeuwes
President, Chief Executive Officer &
Director
James E. Brown
Corporate headquarters
Cupertino, California

Forecasts